The Board of Directors warmly welcomes David Reddy to the MMV team.
MMV welcomes Dr David Reddy as our new CEO. We are delighted to have him on board! He takes over from Dr Dennis Schmatz, who led MMV capably for the past 8 months and will now resume his role on the Expert Scientific Advisory Committee and on MMV’s Board of Directors.
David’s appointment as CEO is timely. There’s never a dull moment at MMV, and 2011 promises to be yet another year of excitement and accomplishments. We have already helped develop a paediatric ACT and have supported WHO prequalification for the treatment of severe malaria. This year we expect to add more feathers to our cap: we await regulatory approval of two new products from our antimalarial pipeline, are organizing a stakeholders’ meeting in Africa, and are planning a strong presence of our science and access teams at several important international conferences.
MMV looks forward to David’s leadership as we work towards realizing our mission to help rid the world of malaria.
Lynda, Baroness Chalker of Wallasey
Chairman, MMV Board of Directors